Soleno Therapeutics Inc (NAS:SLNO)
$ 52.7 -0.94 (-1.75%) Market Cap: 2.05 Bil Enterprise Value: 1.82 Bil PE Ratio: 0 PB Ratio: 7.21 GF Score: 38/100

Soleno Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 12:10PM GMT
Release Date Price: $26.8 (+504.97%)
Kristen Kluska
Cantor Fitzgerald - Analyst

Hi, good morning, everybody, and welcome to the Cantor Global Healthcare Conference 2023. I'm Kristen Kluska, one of the analysts. It's my great pleasure to introduce Dr. Anish Bhatnagar, the CEO of Soleno Therapeutics, who I think has set the new standard for how to properly start a Cantor Healthcare Conference.

Anish Bhatnagar
Soleno Therapeutics, Inc. - CEO

Thank you, Kristen. Good morning, everyone. Thank you all for being here today. I know that we just put out a press release with new data, and I'm sure you want to hear that first. But for the sake of those who don't know the story, I'm going to walk a little bit through the basics, how we got where we got to, and then I'll take a couple of questions.

So our forward-looking statement slide.

I want to talk a little bit about the disease Prader-Willi syndrome. So PWS is a genetic disease. It happens spontaneously in about 1 in 15,000 live births. It's typically not inherited. Translates to about between 10 and 20,000 patients in the US and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot